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Sleep and Endocrinology: 
Hypothalamic-pituitary- adrenal axis and 
growth hormone 
The supra-chiasmatic nucleus (SCN) is the primarily biological clock determining the 
circadian rhythm. The neurons of the nucleus making this clock have inherent rhythm 
and set in biological day and night. These periods usually corresponds to day/night, and 
indirectly to sleep-wakefulness cycle, in most individuals. Retino-hypothalamic tract 
carrying photic information from the retina provides the most important input to 
maintain the inherent rhythm of the SCN. The rhythmic discharges from the SCN to 
various neurons of the central nervous system, including pineal gland and 
hypothalamus, translate into circadian rhythm characteristic of several hormones and 
metabolites such as glucose. As a result there is a pattern of hormonal changes 
occurring during cycle of sleep wakefulness. Most characteristic of these changes are 
surge of melatonin with biological night, surge of growth hormone-releasing hormone 
(GHRH) at onset of sleep and surge of corticotropin- releasing hormone (CRH) 
during late part of the sleep. The cause and effect relationship of the hypothalamic 
releasing hormones and their target hormones on various phases of sleep including 
initial non rapid eye movement (NREM) phase at onset of sleep, and rapid eye 
movement (REM) phase near awakening, is an upcoming research area.  Sleep 
electroencephalogram (EEG) determining the onset of NREM and REM sleep is an 
important tool complimenting the studies assessing relationship between various 
hormones and phases of sleep. The slow wave activity (SWA) corresponds to the 
intensity of sleep at its onset during the biological night of an individual. Besides, 
GHRH and CRH, several other peptide and steroid hormones such as growth     
hormone (GH), its secretagogues, ghrelin, neuropeptide Y, estrogen and 
d sulfate are associated or have the potential to change phases of ehydroepiandrosterone 
sleep including initial slow wave-NREM sleep. 
Correspondence : Prof. Ravinder Goswami, Department of Endocrinology and 
Metabolism, All-India Institute of Medical Sciences, Ansari Nagar, New Delhi – 
110029. E-mail: gosravinder@hotmail.com
Ravinder Goswami
Department of Endocrinology and Metabolism
All-India Institute of Medical Sciences, New Delhi
ABSTRACT
The sleep disturbances with aging and 
depression are common and reﬂected as 
impaired SWA in the EEG and early 
morning awakening. Recognition of sleep 
associated endocrine changes has resulted 
into a number of studies assessing sleep 
promoting effect of compounds such as 
melatonin and CRH antagonists. These 
studies have potential implications for 
pa t ients  wi th  s leep  d is turbances 
associated with depression, aging and 
those having frequent night shifts. 
The misalignment of normal circadian 
rhythm and sleep wake cycle, as observed 
during night shift work, has been 
recognized to have important adverse 
consequences. These include difﬁculty in 
maintaining sleep during day time, and 
metabolic derangement such as obesity, 
impaired insulin secretion and associated 
glucose intolerance. Understanding of 
sleep-endocrine physiology is clinically 
important to deal with these adverse 
consequences.     
OVERVIEW
On an average, humans spend one-
third of their life in sleep. The adverse 
effects of misaligned sleep wake cycle, as 
in night shift worker, has given an impetus 
to the research related to the physiology of 
s l e e p  a n d  a s s o c i a t e d  e n d o c r i n e 
disturbances. The inherent aspects of this 
research are the factors determining 
normal sleep wake cycle and changes 
secondary to this. The hormone system 
coupled with nervous system control 
virtually all the major activities of the 
body. It is therefore natural to expect these 
two to have effect on sleep wake cycle. 
The purpose of this review is to present 
salient aspects of sleep physiology in 
relation to endocrine system. The 
information in this review was presented 
in the annual meeting of the National 
Academy of Medical Sciences held at 
Jodhpur, AIIMS, in 2013, and is based on 
two excellent reviews by Morris et al. (1) 
and Steiger (2) and other published data.
Sleep wake cycle and its integration 
with endocrine system :
The normal sleep wake cycle is 
inﬂuenced by circadian rhythm, hormonal 
changes and pressure for sleep after long 
working hours. Its architecture includes 
repeated phases of NREM and REM 
sleep. It begins with NREM sleep, which 
is reﬂected in the EEG as SWA. 
The circadian system is primarily 
governed by the SCN located in the 
anterior hypothalamus with projections to 
the various parts of the brain. Inherent 
rhythmicity of the neurons in this nucleus 
with its downstream effect on hormones 
a n d  a u t o n o m i c  n e r v o u s  s y s t e m 
determines the biological day and night. 
The biological day and night reﬂect 
phases of  act ivi ty and inact ivi ty 
respectively. The SCN entrained by solar 
day and night is responsible for biological 
day and night. Retino-hypothalamic tract 
helps in the integration of internal 
c i r c a d i a n  s y s t e m  w i t h  e x t e r n a l 
environment. This tract conveys the 
important information from external 
world through photic stimuli on the 
ganglion cell of retina to the SCN. Thus, 
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the pulsatility of SCN can be entrained by 
external environment. Other factors, 
which can entrain SCN, are body 
temperature and metabolites.
The circadian rhythm leads to a 
predictable form of change in hormone 
system.  Some of these hormones 
themselves can have overriding effect on 
sleep wake cycle. The salient example of 
this is melatonin hormone, which is 
released during biological night but can be 
used to reset alteration in sleep wake cycle 
induced through jet lag or night shift. 
Another example related to use of 
information regarding endocrine changes 
during sleep is in the treatment of sleep 
disturbance observed in depressed and 
aged individuals. Attempts are on in 
various laboratories assessing the use of 
sleep associated hormones or their 
an tagonis t s  in  modula t ing  s leep 
disturbances.
Sleep and hormones
(A) Hypothalamic pituitary 
somatotroph axis
GHRH, somatostatin, GH, ghrelin 
and other GH secretagogues are important 
sleep modulating hormones (1,2). 
Normally, there is a surge of GH at the 
onset of sleep. In males there is only a 
single peak, but females have additional 
peaks of GH in the middle of the night. 
The sleep has a greater inﬂuence on GH 
than the circadian rhythm, which is 
indicated by the occurrence of GH surges 
irrespective of the onset of sleep during 
day or night. Its occurrence at multiple 
points during night, coinciding with SWA, 
further support the less important role of 
circadian system in explaining the 
association of GH surge with sleep (1,2).  
GHRH is the chief regulator of the GH 
surge and its slow wave sleep (SWS) 
promoting effect has been conﬁrmed both 
by central and intravenous/intranasal 
administration of GHRH peptide in 
experimental animals as well as in human 
volunteers respectively (2-6). Though the 
hormone had no effect in the early 
morning in young subjects, it had a sleep 
promoting effect in normal elderly with 
prolongation of ﬁrst NREM and decrease 
in the number of awakenings (2). 
Interestingly, a sexual dimorphism was 
observed in patients with depression. In 
males, GHRH inhibited cortisol during 
the second half of the night (7). However, 
in females where cortisol levels increased 
during second half, along with sleep 
impairing effect (2). This indicated 
antagonist action of GHRH on CRH-
cortisol during sleep wake cycle in males 
but it has synergistic effect in females. In 
contrast to GHRH, no consistent pattern 
of change in sleep architecture has been 
reported on GH administration. This 
indicates the primary role of GHRH, 
rather  than GH, in  normal  s leep 
architecture (8).
Ghrelin is hunger stimulating 
hormone produced from cells lining the 
fundus of the stomach. Besides, it is an 
endogenous GH secretagogue stimulating 
GH release. Weikel et al showed SWS 
promot ing  e ffec t  o f  in t ravenous 
administration of ghrelin in young males 
(9).  However, in contrast to GHRH, 
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cortisol level increased after Ghrelin. The 
effect of synthetic GH secretagogues like 
GH-releasing peptide-6 and hexarelin are 
also under investigation. Similarly, 
galanin peptide,  which is  wildly 
distributed in brain, and which stimulated 
GH, can also have SWS promoting effect 
in normal males (10). Ghrelin, synthetic 
GH secretagogues and galanin deserve 
further investigation for their possible role 
in altering sleep.
 Somatostatin and octreotide lead 
to impairment in NREM/SWS sleep (11). 
The effect of somatostatin is more marked 
in the elderly than the young subjects. 
Steiger et al., suggested that somatostatin 
antagonist may be of help in the 
modulation of sleep disturbances in 
e lder ly  males  (2) .  The  fac t  tha t 
somatos ta t in  antagonis t  arginine 
increased SWS in elderly male indicated 
that the balance of GHRH/somatostatin in 
favour of GHRH would help sleep 
promotion in elderly.
(B) Hypothalamic pituitary adrenal 
axis
CRH, ACTH and cortisol are 
hormones, which are associated with 
sleep, especially at the termination of 
biological night or near awakening (1,2). 
It is well known that circadian system has 
strong inﬂuence on serum cortisol levels 
in human with level peaking in the 
biological morning and low in the early 
part of the biological night. These 
circadian rhythms are produced through 
hormonal and neuronal pathways. 
Projections from SCN and paraventricular 
nucleus are important for release of CRH. 
Neuronal signals to the intermediate 
lateral column of the spinal cord, and then 
to the adrenal cortex, result in increase in 
serum cortisol. CRH seems to be the prime 
regulator of sleep architecture, followed 
by corticosteroids (1,2). The effect of 
CRH seems to be reciprocal of GHRH, 
because in animal and experimental 
studies CRH administration reduced 
SWS, prolonged sleep latency and 
increased REM sleep (12,13). Besides, 
CRH administration in young volunteers 
also decreased GH surge along with 
increase cortisol after the sleep onset. The 
disturbing effect of CRH on sleep 
increases with aging (14). The importance 
of CRH in sleep disturbance is also 
indicated by the fact that patients with 
depression and elderly subjects have 
increased cortisol activity in the late half 
of the night, especially before wakening. 
It is interesting to recall the sexual 
dimorphism in the action of GHRH in 
females. Unlike males, GHRH in females 
had synergistic effect on CRH. The 
increased CRH/cortisol activity in the 
females, elderly and patients with 
Cushing's disease could explain the high 
prevalence of depression and sleep 
d i s t u r b a n c e s  i n  t h e s e  s u b j e c t s . 
Interestingly, apart from decreasing SWS, 
CRH administration in human led to 
decrease in REM sleep also (2).
Theoretically,  the effect of 
increased CRH described above could 
also be due to increases in the ACTH and 
cortisol activities. All the three hormones 
i.e., CRH, ACTH, GH lead to suppression 
of REM sleep. However, pulsatile 
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administration of synthetic ACTH 
analogue had no effect on cortisol and 
REM activity (2). Steiger et al suggested 
that CRH induced decrease in REM sleep 
in human could reﬂect a direct effect of 
c o r t i s o l  ( 2 ) .  I n  f a c t ,  c o r t i s o l 
administration led to reduced REM sleep 
in young normal males (2). The effect of 
acute and chronic cortisol administration 
were found to be different (2). The acute 
administration of steroids resulted in 
increase SWS and GH release in elderly 
and young controls as well as in patients 
with depression (2,15,16). On the other 
hand, chronic glucocorticoid therapy 
resulted in decreased REM sleep latency, 
increase REM sleep density (17). As 
serum cortisol levels were maximum in 
the early morning hours, when the arousal 
from sleep also occurred, it is highly 
unlikely that cortisol determined the 
circadian rhythm of sleep.
Realizing the importance of CRH 
in sleep disturbances, research is ongoing 
on various CRH antagonist molecules in 
sleep disorders (2). CRH antagonist like 
alpha helical CRH and astressin could 
decrease the stress induced changes in 
sleep in experimental animals (2). 
Similarly, a four weeks trial with CRH 
receptor 1 antagonist (NBI-30775) led to 
increase in the SWS and decrease number 
of awakenings. Paradoxically REM was 
shown to be increased in these studies 
(2,18).  
Misalignment of sleep with circadian 
rhythm and endocrine inﬂuences
One of the important functions of 
the circadian system is to maintain 
homeostasis of essential parameters such 
as body weight, appetite and balance of 
autonomic nervous system activity at 
various points of the day according to the 
requirement of activity. The system works 
in close association with biological day 
and night in most individuals. Long term 
deviation in the close harmony between 
circadian rhythm and sleep wake cycle has 
recently been recognized to result in 
several adverse consequences. A typical 
example of misalignment is seen in night 
shift workers like health professionals. 
Figueiro and White recently reviewed 
data on the effect of rotating night shift 
(19). Circadian disruption resulting from 
rotating shift work was associated with 
increased risk for metabolic syndrome, 
diabetes, cardiovascular disease and 
cancer (19). Marquezea et al investigated 
the relationship between night shift and 
body weight in 446 nursing staff (20). 
Logistic regression analysis showed that 
more time spent during night shift was 
a s soc ia ted  wi th  deve lopment  o f 
overweight/obesity (20). The increased 
risk of obesity associated with night shift 
work might translate into glycemic 
dysregulation. Monk et al., reported 
higher risk of diabetes among 1111 retired 
night shift workers aged > 65 years, with 
odd ratio of two which remained 
signiﬁcant even after adjusting for BMI 
and gender (21). Pan et al., followed 
69269 women aged 42-67 years in Nurses' 
Health Study I (NHS I, 1988-2008), and 
107915 women aged 25-42 in NHS II 
( 1 9 8 9 - 2 0 0 7 )  w i t h o u t  d i a b e t e s , 
cardiovascular disease, and cancer at 
baseline (22). The results showed that an 
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extended period of rotating night shift 
work was associated with increased risk of 
type 2 diabetes in women which was 
partly mediated through body weight (22). 
Caciari et al., studied 163 health workers 
exposed to night work and compared with 
252 similar controls who were not 
e x p o s e d  f o r  a l t e r a t i o n  o f  s o m e 
cardiovascular risk parameters (23). Night 
workers had clinically signiﬁcant changes 
in  serum to ta l  choles tero l ,  HDL 
cholesterol and triglycerides. Puttonen et 
al., studied associations between shift 
work with the metabolic syndrome in 
employees of an airline company (24). 
Findings of the cross-sectional study 
suggest  that  metabolic syndrome 
diagnosed by International Diabetes 
Federation (IDF) criteria and the National 
Institute of Health Adult Treatment Panel 
III (NCEP) guidelines was more prevalent 
among former male shift workers than 
current day workers who had never 
worked in shifts with Odds ratio of 
approximately 2.0. Currently, the 
pathophysiology of the disturbances in 
cardio metabolic system and glycemic 
dysregulation in misalignment of sleep 
with circadian rhythm is not very clear. 
However, alteration in GH, cortisol and 
their inﬂuence on insulin-glucose system 
would be a subject of further study. 
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